Liikehäiriöpäivät

Thursday 7.5.2026

16.30

Coffee and the exhibition

17.00

Opening words
Prof. Jussi Sipilä, North Karelia Clinic of Neurology, Head of Finnish Section of MDS

17.05

How can we improve clinical diagnostics of Parkinson’s disease?
Prof. Valtteri Kaasinen, Turku University Hospital Neuro Center, Finland

17.50

Platinum-level partner, AbbVie: Optimal treatment along the trajectory of Parkinson's Disease – making the right choices at the right time
Dos. Filip Scheperjans, HUS and Aava, Helsinki, Finland

18.20

Coffee break and the exhibition

18.40

Moving Beyond ‘Clinicopathology’: A Biophysical Model of Neurodegeneration
Prof. Alberto Espay, University of Cincinnati, United States

19.30

Panel discussion: From proteins to diagnoses and back again?
Prof. Alberto Espay, prof. Valtteri Kaasinen, prof. Timo Myöhänen

20.00

Platinum-level partner, NordicInfu Care: Lecigon – beneficial clinical effects beyond motor control in advanced PD
Prof. Tobias Warnecke, Klinikum Osnabrück, Germany

20.30

Dinner

22.00

End day 1

Friday 8.5.2026

08.30

Morning coffee and the exhibition

09.10

Patient cases
Prof. Jussi Sipilä 

10.00

Platinu- level partner, Merz Therapeutics: OFF episodes in Parkinson’s disease – Experience and On-Demand Treatment Options with focus on inhaled levodopa in clinical practice.
Dr Lydia López Manzanares, Dept. of Neurology, University Hospital La Princesa, Madrid, Spain.

10.30

Coffee break and the exhibition

10.50

Gold-level partner, Orion Pharma

11.05

Selected recent movement disorders literature
Prof. Jussi Sipilä 

11.40

Silver-level partner, argenx

11.45

Lunch and the exhibition

12.45

Liikehäiriöjaoston asioita ja seuraava kokous
Prof. Jussi Sipilä

13.45

Tilaisuus päättyy